Digital Therapeutics Market Summary

The global digital therapeutics market size was estimated at USD 7.67 billion in 2024 and is projected to reach USD 32.5 billion by 2030, growing at a CAGR of 27.77% from 2025 to 2030. This rapid growth is primarily driven by the cost-effectiveness of digital health technologies for both healthcare providers and patients, as well as the rising penetration of smartphones in developed and developing countries. Digital therapeutics offer accessible, scalable, and personalized treatment options, enabling patients to manage chronic conditions and improve health outcomes while reducing the burden on healthcare systems.

The increasing demand for patient-centric care and integrated healthcare systems is expected to further propel market growth. Supportive reimbursement policies, the impact of the COVID-19 pandemic on accelerating digital health adoption, early signs of insurance coverage for digital therapies, and the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and mental health conditions are additional factors driving market expansion. Digital therapeutics provide real-time monitoring, behavioral interventions, and evidence-based treatment plans, which enhance patient engagement and adherence to therapy.

Key Market Trends & Insights

• North America dominated the digital therapeutics industry globally, with a revenue share of 40.11% in 2024, driven by advanced healthcare infrastructure, high digital health adoption, and strong regulatory support.
• The U.S. digital therapeutics industry held the majority of revenue share at 85.40% in 2024, reflecting widespread use of digital health solutions, investment in technology, and supportive reimbursement frameworks.
• In terms of application, the diabetes segment dominated the market with the largest share of 29.75% in 2024, as digital therapeutics provide effective tools for glucose monitoring, lifestyle management, and patient education.
• In terms of end use, the patient segment held the largest market share of 34.50% in 2024, highlighting the direct benefits of digital therapeutics in self-management and improved health outcomes.

Order a free sample PDF of the Digital Therapeutics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 7.67 Billion
• 2030 Projected Market Size: USD 32.5 Billion
• CAGR (2025-2030): 27.77%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

The global digital therapeutics industry is highly competitive and is dominated by a few renowned companies. Participants are adopting various strategies such as mergers, partnerships, collaborations, and acquisitions to enhance their marketplace presence.

Key Players

• OMADA HEALTH, INC.
• Welldoc, Inc.
• 2Morrow, Inc
• Livongo Health, Inc. (Teladoc Health, Inc.)
• Propeller Health (ResMed)
• Fitbit LLC
• Mango Health
• CANARY HEALTH
• Noom, Inc.
• Pear Therapeutics, Inc.
• Akili Interactive Labs, Inc.
• HYGIEIA
• DarioHealth Corp.
• BigHealth
• GAIA AG
• Limbix Health, Inc. 

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The digital therapeutics market is expected to experience substantial growth as healthcare increasingly embraces technology-driven, patient-centered solutions. Rising chronic disease prevalence, favorable reimbursement policies, and smartphone penetration are accelerating adoption worldwide. North America, led by the U.S., remains the largest market due to advanced infrastructure and high digital health acceptance. With diabetes management and patient-focused applications driving demand, digital therapeutics will play a critical role in improving healthcare accessibility, treatment adherence, and long-term patient outcomes globally.